The human microbiome is a highly complex and dynamic ecosystem that exists in close functional interaction with its host. In the context of cosmetic science, the skin microbiome plays a particularly critical role in maintaining barrier integrity, immune homeostasis, and inflammatory balance. For research and development teams, this necessitates a paradigm shift: cosmetic ingredients can no longer be evaluated solely based on their direct effects on skin cells but must also be assessed in terms of their microbial interactions and ecosystem impact.
In my view, the microbiome can no longer be ignored in cosmetic testing. It plays a decisive role in skin health, resilience, and inflammatory regulation. Testing exclusively on isolated skin cells or even reconstructed epidermis—without incorporating bacteria—fails to reflect the biological reality of human skin. The skin is not sterile, and any model that excludes its microbial component captures only part of the functional response to a formulation.
The Skin Microbiome as a Functional Component of the Barrier
The skin surface is colonized by billions of microorganisms, including bacteria, fungi, and viruses, which together form the skin microbiome. This microbial network is an integral component of the cutaneous barrier. It contributes to maintaining physiological pH, competes with potential pathogens for nutrients and adhesion sites, and modulates immune responses. Commensal species stimulate antimicrobial peptide production and influence epidermal differentiation.
A stable and diverse microbial community is widely considered a hallmark of healthy skin. Disruption of this balance—through aggressive surfactants, unsuitable preservation systems, or repeated barrier damage—can lead to dysbiosis. Such imbalances are associated with acne-prone skin, increased sensitivity, inflammatory dermatoses, and scalp disorders.
A particularly illustrative example is the scalp. In many conventional in vitro assessments, shampoos are primarily evaluated for cleansing performance, irritation potential, and sometimes antifungal efficacy. However, microbial diversity on the scalp is rarely examined in parallel. From accumulated testing experience, it becomes evident that many commonly tested shampoo formulations significantly reduce overall bacterial diversity on the scalp. At the same time, lipophilic yeasts such as Malassezia species often persist due to their specific biological adaptations.
If bacterial diversity decreases while Malassezia remains relatively unaffected, a microbial shift becomes almost inevitable. Reduced competitive pressure can favor yeast dominance, potentially contributing to conditions such as dandruff and seborrheic imbalance. From a microbiological perspective, it is therefore logical that repeated use of strongly microbiome-disruptive shampoos may shift the ecosystem toward a less diverse, yeast-skewed state.
Limitations of Conventional Ingredient Evaluation
Traditional safety and efficacy assessments in cosmetics primarily focus on cellular endpoints such as cytotoxicity, irritation potential, transepidermal water loss (TEWL), barrier repair markers, or collagen synthesis. While essential, these parameters only reflect part of the biological complexity.
A preservative system may be regulatory compliant yet still reduce commensal diversity. A surfactant may achieve excellent cleansing performance while exerting unintended ecological pressure on microbial communities. Without microbiological impact assessment, ingredient evaluation remains incomplete, especially when microbiome-related claims are communicated. Pure keratinocyte monocultures or bacteria-free skin equivalents cannot adequately predict formulation behavior within a living microbial ecosystem.
Microbiome-Conscious Use of Antimicrobial Ingredients in Formulations
Ensuring microbiological product safety is a fundamental requirement in cosmetic development. Preservatives play a critical role in protecting formulations from contamination and guaranteeing consumer safety. However, our experience indicates that many preservatives do not act exclusively within the product matrix. They may also significantly impact the skin’s natural microbiome.
We therefore advocate for a microbiome-conscious formulation strategy based on the following principles:
- Antimicrobial ingredients should be evaluated not only for product preservation efficacy, but also for their potential effects on the skin microbiome.
- Results from cosmetic challenge tests should be included to determine the minimum effective concentration required to ensure product safety.
- Wherever technically feasible, concentrations of preservatives, surfactants, and other microbiome-relevant ingredients should be reduced to the lowest level that maintains product stability while minimizing disruption of the skin’s natural microbial balance.
Product protection and microbiome preservation should not be viewed as conflicting objectives. Instead, they should be considered equally important development parameters in modern cosmetic science. A balanced, evidence-based approach offers both scientific responsibility and strategic differentiation in an increasingly microbiome-aware market.
Advanced Testing Approaches and Specialized Co-Culture Models
Integrating microbial parameters into cosmetic testing requires physiologically relevant methodologies. Reconstructed skin models incorporating defined microbiota, co-culture systems, and biofilm models are increasingly important. These can be combined with molecular techniques such as 16S rRNA sequencing, metagenomics, and metabolomics to assess microbial composition, diversity indices, and functional shifts.
At this interface between toxicology, microbiology, and cosmetic science, Molecularis plays a pivotal role. In addition to GLP-compliant in vitro toxicological testing, Molecularis offers customized R&D solutions specifically focused on skin microbiomes. The company specializes in developing physiologically relevant co-culture systems that replicate the microbial environments of distinct body regions.
These include defined co-culture models for the oral cavity, scalp, oily, dry, and moist skin areas, as well as the vaginal microbiome. Such tailored systems allow ingredient and formulation testing in realistic microbial contexts, enabling differentiated evaluation of microbial stability, diversity preservation, and functional modulation.
Various experimental settings are available, including integration with advanced 3D skin models. By combining cellular and microbial components within unified platforms, these systems allow comprehensive assessment of toxicological safety, efficacy, and microbiome interaction.
Through this integrated approach, the microbiome is addressed not as a marketing trend, but as a biologically essential testing parameter. For raw material suppliers and formulators, incorporating microbiome-relevant endpoints is a decisive step toward scientifically robust product development and sustainable innovation in next-generation cosmetic formulations.
To get in touch visit the Molecularis website
By Dr. habil. Lisa Bäumer
Founder and CEO of Molecularis GmbH and Private Lecturer at FAU, specializing in host-pathogen interactions and microbiome science. Formerly Head of R&D at MyMicrobiome AG, I combine award-winning academic expertise with extensive experience in laboratory infrastructure and diagnostic standards.